My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 346

    1.

    Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, Haller H, Cooper ME, Forbes JM.

    Diabetes. 2004 Nov;53(11):2921-30.PMID: 15504973 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.

    Diabetes. 2008 Feb;57(2):460-9. Epub 2007 Oct 24.PMID: 17959934 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

    Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME.

    FASEB J. 2003 Sep;17(12):1762-4. Epub 2003 Jul 18.PMID: 12958202 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.

    Jeyabal PV, Kumar R, Gangula PR, Micci MA, Pasricha PJ.

    Neurogastroenterol Motil. 2008 Mar;20(3):253-61. Epub 2007 Oct 17.PMID: 17971026 [PubMed - indexed for MEDLINE]Related articles

    5.

    Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?

    McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE.

    Kidney Int. 2007 Aug;72(4):481-8. Epub 2007 Jun 6.PMID: 17554258 [PubMed - indexed for MEDLINE]Related articles

    6.

    Renoprotective effects of a novel inhibitor of advanced glycation.

    Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.

    Diabetologia. 2001 Jan;44(1):108-14.PMID: 11206401 [PubMed - indexed for MEDLINE]Related articles

    7.

    ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

    Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, Cooper ME.

    Diabetes. 2002 Nov;51(11):3283-9.PMID: 12401720 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

    Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SR, Cooper ME, Allen TJ.

    Diabetes. 2004 Jul;53(7):1813-23. Erratum in: Diabetes. 2006 Mar;55(3):862. Thorpe, Susan M [corrected to Thorpe, Susan R]. PMID: 15220206 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.

    Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G.

    Diabetologia. 1997 Oct;40(10):1141-51.PMID: 9349594 [PubMed - indexed for MEDLINE]Related articles

    10.

    The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment.

    Usta MF, Kendirci M, Gur S, Foxwell NA, Bivalacqua TJ, Cellek S, Hellstrom WJ.

    J Sex Med. 2006 Mar;3(2):242-50; discussion 250-2.PMID: 16490017 [PubMed - indexed for MEDLINE]Related articles

    11.

    Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide.

    Mamputu JC, Renier G.

    J Diabetes Complications. 2002 Jul-Aug;16(4):284-93.PMID: 12126787 [PubMed - indexed for MEDLINE]Related articles

    12.

    A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.

    Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, Burrell LM.

    Circ Res. 2003 Apr 18;92(7):785-92. Epub 2003 Mar 6.PMID: 12623881 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of blocking the renin-angiotensin system on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats.

    Zhang L, Ma J, Gu Y, Lin S.

    Nephron Exp Nephrol. 2006;104(3):e103-11. Epub 2006 Jul 12.PMID: 16837815 [PubMed - indexed for MEDLINE]Related articles

    14.

    Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

    Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

    J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?

    Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM.

    Endocrinology. 2007 Feb;148(2):886-95. Epub 2006 Nov 16.PMID: 17110423 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats.

    Kang N, Alexander G, Park JK, Maasch C, Buchwalow I, Luft FC, Haller H.

    Kidney Int. 1999 Nov;56(5):1737-50.PMID: 10571782 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.

    Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G.

    Diabetologia. 1995 Apr;38(4):387-94.PMID: 7796978 [PubMed - indexed for MEDLINE]Related articles

    18.

    Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.

    Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, Meier M, Gueler F, Fiebeler A, Bahlmann FH, Leitges M, Haller H.

    Diabetes. 2004 Aug;53(8):2101-9.PMID: 15277392 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.

    Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M.

    Arch Biochem Biophys. 2003 Nov 1;419(1):55-62. Review.PMID: 14568009 [PubMed - indexed for MEDLINE]Related articles

    20.

    Advanced glycosylation end products, protein kinase C and renal alterations in diabetic rats.

    Rong J, Qiu H, Wang S.

    Chin Med J (Engl). 2000 Dec;113(12):1087-91.PMID: 11776142 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity